Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in enhanced adverse effects for example drowsiness, although the scientific relevance is minimal for most sufferers – monitor the client for adverse effects (e.The goal of this study was to evaluate the anxiolyti